Regen EMS™
Quadriceps Recovery After
Knee Surgery
Methodology
Non-Invasive EMS
Focus Area
Muscular Atrophy
Strategic Research Initiative
Optimising Recovery through
Regenerative Rehabilitation
MSK Doctors is preparing to launch a prospective controlled clinical study. We are moving beyond passive rehabilitation to integrate biological and functional recovery into a single, unified pathway.
Precision Imaging
Utilising advanced diagnostic imaging to map structural integrity and monitor biological tissue response in real-time.
Digital Biomechanics
Quantifying movement patterns and muscular torque to ensure functional recovery matches biological healing.
Regen EMS™ Therapy
The core study component: targeted neuromuscular stimulation to reverse quadriceps atrophy and accelerate surgical outcomes.
“Not just treating symptoms...”
“This initiative reflects our broader focus on optimising recovery at the biological and functional level, rather than relying solely on passive, traditional rehabilitation protocols.”
The Clinical Challenge
Post-Surgical Impediments to Recovery
Following major knee interventions—including arthroplasty and ligament reconstruction—patients face a critical window where standard physiotherapy may not suffice to prevent rapid physiological decline.
Atrophy
Rapid Quadriceps Wasting
Accelerated loss of muscle mass within the first 72 hours post-surgery.
Inhibition
Reduced Voluntary Activation
Neural pathways are often compromised, preventing full muscular recruitment.
Instability
Gait & Kinetic Imbalance
Compromised biomechanics leading to long-term joint instability.
Timeline
Delayed Recovery
Early-stage muscle loss frequently extends the total rehabilitation duration.
Can structured EMS bridge the gap between surgery and success?
Our study evaluates whether integrating Electrical Muscle Stimulation (EMS) into the acute post-operative phase can mitigate early muscle loss and accelerate functional independence compared to traditional physiotherapy alone.
Clinical Significance
Why Muscle Recovery is the
Foundation of Longevity
Gait Confidence
Restoring the psychological and physical assurance required for a natural, fluid stride post-surgery.
Core Stability
Preventing compensatory movements that lead to secondary joint strain and long-term instability.
Active Resumption
Accelerating the timeline for returning to sports, professional duties, and demanding physical hobbies.
Joint Longevity
Preserving the mechanical integrity of the joint by ensuring the surrounding musculature provides optimal support.
Transcending Traditional
Rehabilitation
Conventional recovery pathways often struggle to address the “early window” of muscle inhibition—where neural signals to the quadriceps are dampened by post-surgical trauma.
Regen EMS™ is engineered to bypass this inhibition, facilitating early, active muscle engagement to protect your surgical outcome from the first 48 hours.
The Strategic Nexus
A Multidisciplinary Approach
to Advanced Recovery
Regen EMS™ sits at the critical intersection of four key pillars, engineered to transform the post-operative trajectory.
Regenerative Rehabilitation
Aligning mechanical stimulation with biological healing phases to optimise tissue repair at the cellular level.
Neuromuscular Activation
Bypassing arthrogenic muscle inhibition to re-establish neural pathways and prevent early-stage atrophy.
Home-Based Continuity
Empowering patients with clinical-grade technology to maintain recovery momentum between physiotherapy sessions.
Data-Informed Pathways
Integrating real-world feedback and biomechanical data to tailor the recovery protocol to individual needs.
“Designed to complement, not replace.”
Regen EMS™ acts as a bridge for the early recovery phase—supporting muscle activation when voluntary movement is restricted, ensuring you are ready for the next stage of physical therapy.
Hub
Unified Recovery Framework
Part of a Connected Innovation Ecosystem
Regen EMS™ does not operate in isolation. It is a vital component of the wider MSK Doctors research network, designed to synchronise activation with objective clinical insights.
Measurable Trajectories
By aligning stimulation with digital movement analysis, we create a recovery journey that is fully quantified and transparent.
Evidence-Led Integration
Integrating imaging data with neuromuscular feedback ensures that muscle activation is perfectly timed with biological healing.
Strategic Focus
Shaping the Regenerative Path
The focus of our upcoming work is defined by a simple, clinical objective: to intervene when it matters most.
Early Muscle Health
Intervening in the acute post-operative phase to provide neuromuscular support before significant atrophy can take hold.
Reduced Deconditioning
Mitigating the rapid loss of strength and stamina that traditionally follows major joint surgery and immobilisation.
Functional Confidence
Empowering patients with the physical stability required to engage earlier and more effectively with their physiotherapy.
Regenerative Trajectory
Fostering a recovery environment that promotes biological healing and long-term joint preservation.
“Rather than waiting for strength to return, our aim is to actively support it from the very outset.”
Regen EMS™ is currently in clinical preparation and pending final trial launch.
Forward Momentum
The Next Step in Proactive Recovery
Regen EMS™ represents a paradigm shift in the MSK Doctors philosophy—transforming the post-operative experience from passive waiting to active, biological engagement.
Clinical Intervention
The foundation: High-precision surgical expertise and advanced orthopaedic implants.
Regeneration
The Bridge: Regen EMS™ actively stimulates biological tissue response and neural pathways.
Functional Restoration
The Result: Measurable, data-informed return to high-level activity and daily life.
A smarter, more proactive strategy
for musculoskeletal health.
“Regen EMS™ is an upcoming regenerative rehabilitation initiative within the MSK Doctors ecosystem, focused on supporting early muscle recovery and functional restoration.”
MSK Doctors Research & Development | Project: Regen EMS™ | Status: Development Phase
© 2024 MSK Doctors. All scientific protocols are subject to ethics committee approval.